HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian M Vidal Selected Research

PND 1186

8/2017Inhibition of FAK kinase activity preferentially targets cancer stem cells.
5/2014Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian M Vidal Research Topics

Disease

3Neoplasms (Cancer)
08/2017 - 05/2014
1Triple Negative Breast Neoplasms
08/2017
1Breast Neoplasms (Breast Cancer)
08/2017
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2015
1Neurofibromatosis 2 (Neurofibromatosis Type II)
05/2014
1Malignant Mesothelioma
05/2014

Drug/Important Bio-Agent (IBA)

2PND 1186IBA
08/2017 - 05/2014
1defactinibIBA
08/2017
1Phosphotransferases (Kinase)IBA
08/2017
1Cisplatin (Platino)FDA LinkGeneric
01/2015
1VS-5584IBA
01/2015
1Paclitaxel (Taxol)FDA LinkGeneric
01/2015
1Focal Adhesion Protein-Tyrosine KinasesIBA
05/2014
1Neurofibromin 2 (Merlin)IBA
05/2014
1Aldehyde DehydrogenaseIBA
05/2014
1AsbestosIBA
05/2014

Therapy/Procedure

3Drug Therapy (Chemotherapy)
08/2017 - 05/2014
1Oral Administration
08/2017